IGSF8 and ovarian carcinoma: Our group has previously reported IGSF8 as a potential biomarker of ovarian cancer–derived EVs for early detection (26) and it is possible that chronic stimulation with ovarian cancer–derived EVs triggers IGSF8 release from neighboring cells as well.